Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Octreotide market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Octreotide market segmented into
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Based on the end-use, the global Octreotide market classified into
Treating Severe Diarrhea
Treating Acromegaly
Others
Based on geography, the global Octreotide market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL OCTREOTIDE INDUSTRY
2.1 Summary about Octreotide Industry
2.2 Octreotide Market Trends
2.2.1 Octreotide Production & Consumption Trends
2.2.2 Octreotide Demand Structure Trends
2.3 Octreotide Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Octreotide Injection
4.2.2 Octreotide Powder
4.2.3 Octreotide Microspheres
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Treating Severe Diarrhea
4.3.2 Treating Acromegaly
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Octreotide Injection
5.2.2 Octreotide Powder
5.2.3 Octreotide Microspheres
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Treating Severe Diarrhea
5.3.2 Treating Acromegaly
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Octreotide Injection
6.2.2 Octreotide Powder
6.2.3 Octreotide Microspheres
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Treating Severe Diarrhea
6.3.2 Treating Acromegaly
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Octreotide Injection
7.2.2 Octreotide Powder
7.2.3 Octreotide Microspheres
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Treating Severe Diarrhea
7.3.2 Treating Acromegaly
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Octreotide Injection
8.2.2 Octreotide Powder
8.2.3 Octreotide Microspheres
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Treating Severe Diarrhea
8.3.2 Treating Acromegaly
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Octreotide Injection
9.2.2 Octreotide Powder
9.2.3 Octreotide Microspheres
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Treating Severe Diarrhea
9.3.2 Treating Acromegaly
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Novartis
10.1.2 Sun Pharmaceutical
10.1.3 Chengdu Tiantaishan pharmaceutical
10.1.4 Sinopharm A-Think Pharmaceuticals
10.1.5 Sihuan Pharmaceutical Holdings Group
10.1.6 Shanghai Soho-Yiming Pharmaceuticals
10.1.7 Yibin Pharmaceutical
10.2 Octreotide Sales Date of Major Players (2017-2020e)
10.2.1 Novartis
10.2.2 Sun Pharmaceutical
10.2.3 Chengdu Tiantaishan pharmaceutical
10.2.4 Sinopharm A-Think Pharmaceuticals
10.2.5 Sihuan Pharmaceutical Holdings Group
10.2.6 Shanghai Soho-Yiming Pharmaceuticals
10.2.7 Yibin Pharmaceutical
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Octreotide Product Type Overview
Table Octreotide Product Type Market Share List
Table Octreotide Product Type of Major Players
Table Brief Introduction of Novartis
Table Brief Introduction of Sun Pharmaceutical
Table Brief Introduction of Chengdu Tiantaishan pharmaceutical
Table Brief Introduction of Sinopharm A-Think Pharmaceuticals
Table Brief Introduction of Sihuan Pharmaceutical Holdings Group
Table Brief Introduction of Shanghai Soho-Yiming Pharmaceuticals
Table Brief Introduction of Yibin Pharmaceutical
Table Products & Services of Novartis
Table Products & Services of Sun Pharmaceutical
Table Products & Services of Chengdu Tiantaishan pharmaceutical
Table Products & Services of Sinopharm A-Think Pharmaceuticals
Table Products & Services of Sihuan Pharmaceutical Holdings Group
Table Products & Services of Shanghai Soho-Yiming Pharmaceuticals
Table Products & Services of Yibin Pharmaceutical
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Octreotide Market Forecast (Million USD) by Region 2021f-2026f
Table Global Octreotide Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Octreotide Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Octreotide Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Octreotide Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Octreotide Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Octreotide Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Octreotide Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Octreotide Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Octreotide Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Octreotide Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Microspheres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treating Severe Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treating Acromegaly Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Microspheres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treating Severe Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treating Acromegaly Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Microspheres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treating Severe Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treating Acromegaly Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Microspheres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treating Severe Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treating Acromegaly Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Microspheres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treating Severe Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treating Acromegaly Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Microspheres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treating Severe Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treating Acromegaly Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreotide Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Octreotide Sales Revenue (Million USD) of Sun Pharmaceutical 2017-2020e
Figure Octreotide Sales Revenue (Million USD) of Chengdu Tiantaishan pharmaceutical 2017-2020e
Figure Octreotide Sales Revenue (Million USD) of Sinopharm A-Think Pharmaceuticals 2017-2020e
Figure Octreotide Sales Revenue (Million USD) of Sihuan Pharmaceutical Holdings Group 2017-2020e
Figure Octreotide Sales Revenue (Million USD) of Shanghai Soho-Yiming Pharmaceuticals 2017-2020e
Figure Octreotide Sales Revenue (Million USD) of Yibin Pharmaceutical 2017-2020e